Ian Schofield looks at why international efforts are being hindered by the lack of a harmonised approach, controversy over intellectual property issues and the increasing use of the internet as a conduit for counterfeit medicines.
With medicines counterfeiting offering high potential for financial gains with a relatively low risk of detection and prosecution, it is easy to see why the trade is flourishing...
Please login to read the full article.
